These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11280725)

  • 21. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation.
    Spitz FR; Nguyen D; Skibber JM; Meyn RE; Cristiano RJ; Roth JA
    Clin Cancer Res; 1996 Oct; 2(10):1665-71. PubMed ID: 9816114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy.
    Pützer BM; Stiewe T; Crespo F; Esche H
    Gene Ther; 2000 Aug; 7(15):1317-25. PubMed ID: 10918503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
    Nielsen LL; Dell J; Maxwell E; Armstrong L; Maneval D; Catino JJ
    Cancer Gene Ther; 1997; 4(2):129-38. PubMed ID: 9080122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A recombinant adenoviral vector expressing full-length human retinoblastoma susceptibility gene inhibits human tumor cell growth.
    Demers GW; Harris MP; Wen SF; Engler H; Nielsen LL; Maneval DC
    Cancer Gene Ther; 1998; 5(4):207-14. PubMed ID: 9694072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL
    Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of bax mutations in apoptosis in colorectal cancers with microsatellite instability.
    Miquel C; Borrini F; Grandjouan S; Aupérin A; Viguier J; Velasco V; Duvillard P; Praz F; Sabourin JC
    Am J Clin Pathol; 2005 Apr; 123(4):562-70. PubMed ID: 15743744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex.
    Nguyen DM; Wiehle SA; Koch PE; Branch C; Yen N; Roth JA; Cristiano RJ
    Cancer Gene Ther; 1997; 4(3):191-8. PubMed ID: 9171938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus.
    Anderson SC; Johnson DE; Harris MP; Engler H; Hancock W; Huang WM; Wills KN; Gregory RJ; Sutjipto S; Wen SF; Lofgren S; Shepard HM; Maneval DC
    Clin Cancer Res; 1998 Jul; 4(7):1649-59. PubMed ID: 9676839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
    Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
    Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
    Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
    Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes.
    Woerner SM; Benner A; Sutter C; Schiller M; Yuan YP; Keller G; Bork P; Doeberitz Mv; Gebert JF
    Oncogene; 2003 Apr; 22(15):2226-35. PubMed ID: 12700659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily.
    Du Y; Carling T; Fang W; Piao Z; Sheu JC; Huang S
    Cancer Res; 2001 Nov; 61(22):8094-9. PubMed ID: 11719434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reciprocal relationship between the tumor suppressors p53 and BAX in primary colorectal cancers.
    Simms LA; Radford-Smith G; Biden KG; Buttenshaw R; Cummings M; Jass JR; Young J; Meltzer SJ; Leggett BA
    Oncogene; 1998 Oct; 17(15):2003-8. PubMed ID: 9788444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The p53-independent tumoricidal activity of an adenoviral vector encoding a p27-p16 fusion tumor suppressor gene.
    Patel SD; Tran AC; Ge Y; Moskalenko M; Tsui L; Banik G; Tom W; Scott M; Chen L; Van Roey M; Rivkin M; Mendez M; Gyuris J; McArthur JG
    Mol Ther; 2000 Aug; 2(2):161-9. PubMed ID: 10947944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.
    Oakley R; Phillips E; Hooper R; Wilson D; Partridge M
    Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
    Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M
    Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
    Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM
    Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers.
    Woerner SM; Kloor M; Schwitalle Y; Youmans H; Doeberitz Mv; Gebert J; Dihlmann S
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1080-9. PubMed ID: 17726700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.
    Wiman KG
    Adv Cancer Res; 2007; 97():321-38. PubMed ID: 17419952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
    Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.